Map Pharmaceuticals raises $52 million

Map Pharmaceuticals Inc. (NASDAQ:MAPP) raised $52 million through the sale of 3.9 million shares at $13.40 in a follow-on underwritten by BofA Merrill Lynch. Map proposed the offering late Tuesday when its share price was $14.11. The stock was down $0.81 to $13.30 on Wednesday. ...